Clinical Trial Update: Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial comparing MenACYW Conjugate Vaccine to a meningococcal reference vaccine and evaluating administration alone or with two other vaccines in healthy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACYW Conjugate Vaccine (MenACWY conjugate vaccine)
• Meningococcal reference vaccine

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Status: COMPLETED | Results posted: 2023-06-06